HK1135972A1 - 4-substituted azaadamantane derivatives and methods of use thereof 4- - Google Patents
4-substituted azaadamantane derivatives and methods of use thereof 4-Info
- Publication number
- HK1135972A1 HK1135972A1 HK10101953.1A HK10101953A HK1135972A1 HK 1135972 A1 HK1135972 A1 HK 1135972A1 HK 10101953 A HK10101953 A HK 10101953A HK 1135972 A1 HK1135972 A1 HK 1135972A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- methods
- azaadamantane derivatives
- substituted
- substituted azaadamantane
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Psychology (AREA)
- Addiction (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Toxicology (AREA)
- Endocrinology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US89675107P | 2007-03-23 | 2007-03-23 | |
PCT/US2008/057647 WO2008118745A1 (en) | 2007-03-23 | 2008-03-20 | 4-substituted azaadamantane derivatives and methods of use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1135972A1 true HK1135972A1 (en) | 2010-06-18 |
Family
ID=39788936
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK10101953.1A HK1135972A1 (en) | 2007-03-23 | 2010-02-24 | 4-substituted azaadamantane derivatives and methods of use thereof 4- |
Country Status (9)
Country | Link |
---|---|
US (2) | US8163915B2 (ja) |
EP (3) | EP2139891B1 (ja) |
JP (1) | JP5394939B2 (ja) |
CN (2) | CN102690265A (ja) |
CA (1) | CA2679876A1 (ja) |
ES (1) | ES2391596T3 (ja) |
HK (1) | HK1135972A1 (ja) |
MX (1) | MX2009010176A (ja) |
WO (1) | WO2008118745A1 (ja) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2139891B1 (en) * | 2007-03-23 | 2012-09-05 | Abbott Laboratories | 4-substituted azaadamantane derivatives and methods of use thereof |
EP3233087B1 (en) | 2014-12-16 | 2019-10-02 | Axovant Sciences GmbH | Geminal substituted quinuclidine amide compounds as agonists of alpha-7 nicotinic acetylcholine receptors |
AU2016274694A1 (en) | 2015-06-10 | 2018-01-18 | Axovant Sciences Gmbh | Aminobenzisoxazole compounds as agonists of A7-nicotinic acetylcholine receptors |
JP2018523707A (ja) | 2015-08-12 | 2018-08-23 | アクソバント サイエンシズ ゲーエムベーハー | α7−ニコチン性アセチルコリン受容体のアゴニストとしてのジェミナル置換アミノベンゾイソオキサゾール化合物 |
EP3409659B1 (en) * | 2016-01-26 | 2020-12-30 | Tohoku University | Adamantane derivative and use thereof |
MY198328A (en) | 2017-08-02 | 2023-08-24 | Neusignal Therapeutics Inc | Adamantylmethylamine Derivative and use Thereof as Pharmaceutical |
JP7380264B2 (ja) | 2020-01-29 | 2023-11-15 | 住友金属鉱山株式会社 | オートクレーブの冷却器具及び冷却方法 |
GB202006382D0 (en) | 2020-04-30 | 2020-06-17 | Spermatech As | Use |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8523211D0 (en) | 1985-09-19 | 1985-10-23 | Beecham Group Plc | Compounds |
US5260303A (en) | 1991-03-07 | 1993-11-09 | G. D. Searle & Co. | Imidazopyridines as serotonergic 5-HT3 antagonists |
US5280028A (en) | 1992-06-24 | 1994-01-18 | G. D. Searle & Co. | Benzimidazole compounds |
US5434151A (en) | 1992-08-24 | 1995-07-18 | Cytomed, Inc. | Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase |
US5840903A (en) * | 1992-07-27 | 1998-11-24 | G. D. Searle & Co. | 4-aminomethyl-1-azaadamantane derived benzamides |
JP3235913B2 (ja) * | 1993-07-30 | 2001-12-04 | エーザイ株式会社 | アミノ安息香酸誘導体 |
US5399562A (en) * | 1994-02-04 | 1995-03-21 | G. D. Searle & Co. | Indolones useful as serotonergic agents |
ES2199561T3 (es) * | 1998-04-02 | 2004-02-16 | Targacept, Inc. | Derivados de azatriciclo(3.3.1.1)decano y composiciones farmaceuticas que los contienen. |
US5986100A (en) * | 1998-04-02 | 1999-11-16 | Crooks; Peter Anthony | Pharmaceutical compositions and methods for use |
US5952339A (en) | 1998-04-02 | 1999-09-14 | Bencherif; Merouane | Pharmaceutical compositions and methods of using nicotinic antagonists for treating a condition or disorder characterized by alteration in normal neurotransmitter release |
US6093724A (en) * | 1998-08-18 | 2000-07-25 | Ucb, S.A. | Muscarinic agonists and antagonists |
US6468998B1 (en) * | 1998-11-02 | 2002-10-22 | Mitsubishi Pharma Corporation | Pyrrolidine compounds and medicinal utilization thereof |
US7897766B2 (en) * | 2005-09-23 | 2011-03-01 | Abbott Laboratories | Amino-aza-adamantane derivatives and methods of use |
EP2139891B1 (en) * | 2007-03-23 | 2012-09-05 | Abbott Laboratories | 4-substituted azaadamantane derivatives and methods of use thereof |
-
2008
- 2008-03-20 EP EP08732558A patent/EP2139891B1/en active Active
- 2008-03-20 MX MX2009010176A patent/MX2009010176A/es active IP Right Grant
- 2008-03-20 EP EP12155558A patent/EP2497771A1/en not_active Withdrawn
- 2008-03-20 CN CN201210167195XA patent/CN102690265A/zh active Pending
- 2008-03-20 JP JP2009554738A patent/JP5394939B2/ja not_active Expired - Fee Related
- 2008-03-20 WO PCT/US2008/057647 patent/WO2008118745A1/en active Application Filing
- 2008-03-20 CN CN200880009570XA patent/CN101641357B/zh not_active Expired - Fee Related
- 2008-03-20 US US12/052,061 patent/US8163915B2/en not_active Expired - Fee Related
- 2008-03-20 CA CA002679876A patent/CA2679876A1/en not_active Abandoned
- 2008-03-20 ES ES08732558T patent/ES2391596T3/es active Active
- 2008-03-20 EP EP12150281A patent/EP2455383A3/en not_active Withdrawn
-
2010
- 2010-02-24 HK HK10101953.1A patent/HK1135972A1/xx not_active IP Right Cessation
-
2012
- 2012-03-23 US US13/428,090 patent/US20120196890A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP5394939B2 (ja) | 2014-01-22 |
CA2679876A1 (en) | 2008-10-02 |
JP2010522203A (ja) | 2010-07-01 |
CN101641357A (zh) | 2010-02-03 |
EP2139891A1 (en) | 2010-01-06 |
CN102690265A (zh) | 2012-09-26 |
EP2497771A1 (en) | 2012-09-12 |
EP2455383A2 (en) | 2012-05-23 |
WO2008118745A1 (en) | 2008-10-02 |
EP2139891A4 (en) | 2010-01-06 |
EP2455383A3 (en) | 2012-09-19 |
CN101641357B (zh) | 2013-09-18 |
EP2139891B1 (en) | 2012-09-05 |
US20080255180A1 (en) | 2008-10-16 |
MX2009010176A (es) | 2009-10-12 |
US20120196890A1 (en) | 2012-08-02 |
ES2391596T3 (es) | 2012-11-28 |
US8163915B2 (en) | 2012-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1254895A1 (zh) | 苄基苯衍生物及使用方法 | |
IL198397A0 (en) | Anilinopiperazine derivatives and methods of use thereof | |
EP2188295A4 (en) | PYRIDINE DERIVATIVES AND METHODS OF USE | |
HK1147254A1 (en) | 5-anilinoimidazopyridines and methods of use 5- | |
ZA200906062B (en) | Benzimidazole derivatives and methods of use thereof | |
HRP20160902T1 (hr) | Pripravci i postupci uporabe forbolskih estera | |
SG10201405568UA (en) | 4-substituted pyridin-3-yl-carboxamide compounds and methods of use | |
IL213596A0 (en) | Heterocyclic compounds and methods of use | |
EP2191458A4 (en) | FINGER-FITTED DEVICES AND METHODS OF USE THEREOF | |
EP2264017A4 (en) | Heterocyclic derivative and its use | |
IL210412A0 (en) | Heterocyclic derivatives and uses thereof | |
ZA201001860B (en) | Pyridazinone derivatives and use thereof as p2z7 receptor inhibitors | |
IL236830A0 (en) | Diazahomoredene derivatives and methods of using them | |
IL205464A0 (en) | Keratin derivatives and methods of making same | |
IL206125A0 (en) | Azaindolizines and methods of use | |
ZA201000183B (en) | Quinazolinone compounds and methods of use thereof | |
HK1135972A1 (en) | 4-substituted azaadamantane derivatives and methods of use thereof 4- | |
EP2134352A4 (en) | WNT COMPOSITIONS AND METHODS FOR THEIR USE | |
IL208771A0 (en) | Iminopyridine derivatives and use thereof | |
IL196594A0 (en) | Derivatives of 4-trimethylammonium-3-aminobutyrate and 4-trimethylphosphonium-3-aminobutyrate as cpt-inhibitors | |
EP2001467A4 (en) | HETEROCYCLIC SPIROCYCLIC DERIVATIVES AND METHODS FOR THEIR USE | |
EP2099299A4 (en) | OXAZOLIDINONE DERIVATIVES AND METHOD FOR THEIR USE | |
ZA201004894B (en) | Nuctraceutical composition and methods of use | |
GB0914782D0 (en) | Perfluoroparacyclophane and methods of synthesis and use thereof | |
ZA201004893B (en) | Nuctraceutical composition and methods of use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20160320 |